Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MUST Imaging
Los Angeles, California, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The MUST imaging system has demonstrated clinical safety and patient acceptance as a more comfortable alternative to mammography in a truncated pilot trial at Beth-Israel Deaconess Medical Center. A European clinical trial for CE mark certification and an NIH proposal for HIFU-guided ablation are ongoing. The US pilot was halted due to COVID but partial data showed safety and workflow integration.
- Therapeutic areas
- Oncology
- Modalities
- DeviceHigh-intensity focused ultrasound ablation system
- Industry
- Medical Imaging
02
Partnerships
Cleveland Clinic (NIH grant proposal collaboration)
Beyond the preview
Go deeper on MUST Imaging.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MUST Imaging.